Filing Flows

Filing Flows › Companies › Sabra Health Care REIT › Timeline

Sabra Health Care REIT stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+18.4% to $21.02

Sabra Health Care REIT (SBRA) stock rose 18% over the last 252 sessions, to $21.02. On the way it reported 4 quarters, its insiders filed 1 open-market trade and 1 Form 144 notice of planned sales, and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.

SBRA: a year of the stock with every disclosure on itSBRA: a year of the stock with every disclosure on it$18.38$19.73$21.08$22.43◆2026-01-05 · Directors and officers: departures, appointments, pay●2026-02-12 · Earnings: missed the EPS estimate by -33.9%▼2026-03-25 · Flores Jessica sold $302K●2026-04-29 · Earnings: beat the EPS estimate by 0.4%●2026-08-03 · Earnings: missed the EPS estimate by -10.2%▽2026-09-08 · Form 144: Richard K. Matros plans to sell $4.2M●2026-11-02 · Earnings: beat the EPS estimate by 15.4%◆8-K event●Earnings report▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 2, 2026EarningsEarnings: beat the EPS estimate by 15.4%−0.1% (+0.4% vs SPY)+6.3% (+9.0% vs SPY)—
Sep 8, 2026Form 144Form 144: Richard K. Matros plans to sell $4.2M+0.1% (+0.7% vs SPY)−1.4% (−0.2% vs SPY)−8.3% (−9.7% vs SPY)
Aug 3, 2026EarningsEarnings: missed the EPS estimate by -10.2%−2.7% (−4.1% vs SPY)−0.6% (−4.1% vs SPY)−2.2% (−4.9% vs SPY)
Apr 29, 2026EarningsEarnings: beat the EPS estimate by 0.4%−0.8% (−0.8% vs SPY)−0.6% (−2.3% vs SPY)+0.3% (−5.5% vs SPY)
Mar 25, 2026Insider saleFlores Jessica sold $302K+0.6% (0.0% vs SPY)−2.6% (−2.1% vs SPY)+0.9% (−7.2% vs SPY)
Feb 12, 2026EarningsEarnings: missed the EPS estimate by -33.9%+3.3% (+4.8% vs SPY)+3.6% (+4.7% vs SPY)+6.6% (+11.0% vs SPY)
Jan 5, 20268-KDirectors and officers: departures, appointments, pay−0.4% (−1.0% vs SPY)+0.7% (−0.9% vs SPY)−4.3% (−5.2% vs SPY)

Insiders’ record here

In the year on the chart, Sabra Health Care REIT's insiders reported 0 open-market buys ($0) and 1 sale ($302K). Of the 1 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −14.5%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Sabra Health Care REIT: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.